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Background: In Qatar more than 70% 0f the adults are overweight and obese. Different adiposity
assessment methods have been proposed to identify individuals at cardio-metabolic risk.
Purpose: This study aimed to compare anthropometric indicators with Dual-energy X-ray
absorptiometry (DXA) –derived adiposity indicators in predicting cardio-metabolic risk
among Qatari adults.
Patients and Methods: A random sample of five hundred and fifty-eight (558) healthy
Qatari adults (men and women) aged 20 to 50 years was obtained from Qatar Biobank
survey data. Anthropometric data (weight, height, and waist circumference), the DXA-
derived data, and cardio-metabolic (CM) risk parameters were analyzed. A Spearman
partial correlation coefficient, Receiver Operating Characteristics (ROC) curve and an
area under curve (AUC) were used to assess the predicting ability of adiposity indicators
for CM risk factors.
Results: Adiposity indices (anthropometric and DXA) were significantly correlated with
most of the CM indicators (r= −0.292 to 0.486, p< 0.001). The AUC of waist to height ratio
(WHtR) was significantly higher than that of body mass index (BMI) and waist circumfer-
ence (WC) in the prediction of low high density lipoprotein (HDL) (AUC=0.65, AUC=0.59;
AUC=0.64), high low density lipoprotein (LDL) (AUC=0.67; AUC=0.62; AUC=0.66), high
cholesterol (AUC=0.66; AUC=0.63; AUC=0.63), and high Homeostatic Model Assessment-
(HOMA) (AUC= 0.81; AUC= 0.78; AUC=0.78). Among DXA- parameters, trunk fat had the
highest AUCs for total cholesterol (AUC= 0.64, CI=0.56, 0.73), triglycerides and glucose
index (TyG) (AUC=0.69, CI=0.64, 0.74), and HOMA (AUC=0.78, CI= 0.73, 0.84).
Conclusion: Results of the present study show that adiposity indicators (WC and WHtR)
are clinically valuable tools to identify individuals at risk of CVD compared to DXA–derived
parameters, while DXA can provide more accurate estimates.
Keywords: Qatar Biobank, adiposity indices, cardiometabolic indicators, dual-energy x-ray
absorptiometry
Background
The prevalence of obesity in Qatar is at an alarming rate. Results of the Stepwise
survey conducted by the Supreme Council of Health (SCH) showed that the
prevalence of overweight among Qatari was 28.7% (25.1% men and 32.2%
women), and 41.1% were obese (43.2% men and 39.5% women).1 Several epide-
miological studies have documented the strong association between obesity and the
development of cardio-metabolic risks (CM) such as hypertension, insulin resis-
tance, diabetes mellitus (T2DM), and dyslipidemia, which contribute to the
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development of cardiovascular diseases (CVD).2,3 The
excess of adipose tissue is involved in the pathogenesis
of hypertension, T2DM, and CVD.4,5 Elucidating the asso-
ciation between adiposity and CM risk factors is very
important in the prevention of non-communicable diseases
(NCD). Therefore, it is necessary to choose the ideal
adiposity measure that can assist in predicting the devel-
opment of diseases and identifying individuals at risk.
Several methods have been used in clinical practices to
assess adiposity. Anthropometrics measurements, weight,
height, BMI, WC, WHtR, and waist to hip ratio (WHR)
have been used globally in researches. These methods are
easy to adopt, inexpensive, and quick. Among thesemeasures,
BMI is the most used indicator of obesity, and has its limita-
tions. BMI depends only on height and weight disregarding
factors such as age, sex, ethnicity, and muscle mass.6 In
addition, BMI does not take body fat distribution into con-
sideration, which is an important factor as abdominal adipos-
ity is strongly associated with high risk of CM diseases.7
Several studies reported that abdominal obesity, parti-
cularly, visceral obesity, is associated with a cluster of
atherogenic metabolic abnormalities referred to as the
metabolic syndrome.8–10 WC as a measure of central obe-
sity was used, as an accurate indicator of CM risk com-
pared to BMI.7 Different studies have revealed that WC is
as effective as BMI because it does not take height into
consideration and there can be under or over estimation of
indicating CM risk in tall or short adults.11
However, anthropometric measures do not distinguish
between either fat and lean mass or visceral fat tissue or
subcutaneous adipose tissue within the abdomen.12 In order
to overcome the weakness of anthropometric indices, a direct
method was proposed to estimate body fat and fat distribution.
DXA is considered as a gold standard to assess body composi-
tion. It is a valid technique for assessing body composition, as
it is able to quantitate whole body and regional fat mass, lean
mass, and bone mineral density.13 Its use in clinical practice
and in research is limited as a result of its accessibility and
cost.14,15 However, the selection of the best adiposity indices
to predict CM risk is controversial. This research aim is to
determine the best and most effective indicator in predicting
high CM risk factors among Qatari adults.
Materials and Methods
Study Population
The study is a population based cross-sectional survey
among Qatari adults (men and women) and long term
residents (individuals living in the country for ≥ 15
years) aged ≥18 years. This study is within the framework
of Qatar Biobank, which is the first Qatar national popula-
tion based prospective cohort study that includes the col-
lection of biological samples, with long-term storage of
data and samples for future research.16 A random sample
of eight hundred and ninety-two (892) Qatari adults (men
and women) aged 20 to 50 years was obtained from Qatar
Biobank survey data. Of those obtained, three hundred and
thirty-four (334) were excluded because they were not
involved in overnight fasting. Finally, a total of 558 parti-
cipants were included in the present study. The totality of
participants were not diagnosed with the following dis-
eases diabetes, hypertension, dyslipidemia and cardiovas-
cular diseases. They were not under any medical treatment
that can affect cardiometabolic variables. All participants
provided a written informed consent. The study was
approved by the Institutional Review Board of Qatar
Biobank. The identity of participants was not revealed,
and an identification number was allocated to each parti-
cipant and was used in whole data analysis.
Obesity Indicators: Anthropometric and
DXA Derived Parameters
Trained staff in Qatar Biobank clinics using standard meth-
ods measured the anthropometric indicators. Body weight
(kg) and height (cm) were measured in light clothing without
shoes with a calibrated scale and a wall-mounted stadi-
ometer. WC was determined at the midpoint between the
last rib and the top of the iliac crest with stretch-resistant
tape. BMI was calculated as weight (kg) divided by square of
the height (m) waist to height ratio (WHtR) was calculated by
dividing WC by height. Overall adiposity (total fat mass (g),
total body fat (TBF%) and regional fat distribution (trunk,
leg, android and gynoid fat mass (g) were performed with
DEXA –Full body iDXA (GE) scan scanners. DXA derived
parameters were used to calculate different ratios such as
trunk/leg fat and android/gynoid fat ratio.
Data Collection
All measurements were performed by trained technicians
and nurses at the Qatar Biobank clinic. Systolic and dia-
stolic blood pressure (SBP and DBP) was determined in
triplicate with the use of mercury sphygmomanometer, and
the average of repeated measurements taken into analyses.
Blood samples were collected after overnight fasting
and used to measure plasma glucose, glycated hemoglobin
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(HbA1C), high density lipoprotein cholesterol (HDL),
insulin, and triglyceride levels using standard laboratory
enzymatic methods. LDL was calculated using the
Friedewald formula.17 TyG was calculated using the equa-
tion: Ln [TG (mg/dL) × glucose (mg/dL)/2.18,19 HOMA
was calculated using the formula: fasting glucose 9mg/dL
× fasting insulin (uU/mL)/405.20
Statistical Analysis
Data were analyzed using Statistical Package for the Social
Sciences version 23 (SPSS Inc, Chicago). We used descrip-
tive statistics with means and standard deviations (SD) for
continuous variables or percentages for categorical variables
to summarize characteristics of the study population. t -test
and chi-square test (χ2) were used to compare body adiposity
and CVD biomarkers between gender. Spearman partial cor-
relation coefficient was used to evaluate the association
between anthropometric, DXA, and CM risk parameters.
ROC curves were conducted and the area under curve
(AUC) was performed with a 95% confidence interval
(95% CI) to assess the accuracy of adiposity indicators
(trunk, legs, android, gynoid, trunk/leg, android/gynoid, %
BF, total fat), and anthropometric indicators (BMI, WC,
WHtR) for predicting abnormality of total cholesterol,
LDL, HDL, TG, TC, HOMA, and TyG. Subjects at CM
risks were identified according to the NCEP(ATP III) guide-
lines given as: SBP> 130 mmHg; DBP>85 mmHg; HDL<
1.04 mmol/L (male) and HDL<1.29 mmol/L (female);21 TG
>1.7 mmol/L; LDL >3.5 mmol/L; TC>5.2 mmol/L;
HbA1c≥6.1%; HOMA-IR ≥2.28,22 and TyG≥ 8.65.23
Results
Table 1 shows the anthropometric characteristics of the study
population. Men and women in the sample were comparable
in terms of mean age, BMI, WHtR, trunk fat, and android.
Men had higher WC, total body fat, trunk fat to leg fat ratio,
and android, while women had higher % body fat, trunk fat,
legs fat and gynoid. The prevalence of general and abdominal
obesity was significantly higher among women compared to
men (28.6% vs 15.8% and 15.8% vs 7.7%), respectively.
Table 2 shows the cardio-metabolic risk parameters.
Results indicated that men had significantly greater mean
SBP, DBP, LDL, TG, glucose, TyG index, and TG/HDL,
while women had significantly higher mean of HDL, insulin
and HOMA-IR. There were no significant differences in total
cholesterol and HbA1C between men and women, respec-
tively. The prevalence of participants with low HDL, high
LDL, high TG, and HOMA-IR was not statistically different
between men and women. The rate of participants with high
TyG was significantly higher for women than men (11.6% vs
15.1%, P=0.002). The prevalence of prediabetes among total
population was 3.3% and the highest rate was observed
among men (2.2% vs 1.1%, p=0.022).
Partial correlation coefficients between adiposity indices
and CM risk parameters after adjusting for age and gender
are presented in Table 3. In general, adiposity indices
(anthropometric and DXA) were significantly correlated
Table 1 Anthropometric Characteristics of the Study Population
Variable Male Female P
(N= 213) (N=345)
Age (y) 31.9 ± 7.4 30.9 ± 7.3 0.116
BMI (kg/m2) 25.9 ± 0.3 26.8 ± 0.3 0.068
WC (cm) 85.1 ± 0.7 77.0 ± 0.9 < 0.001
WHtR 0.49 ± 0.01 0.48 ± 0.01 0.086
Total body fat (g) 23,556.9 ± 693.4 22,943.8 ± 573.0 < 0.001
% Body fat 29.7 ± 7.5 42.4 ± 6.5 < 0.001
Trunk/legs fat 1.147 ± 0.014 0.923 ± 0.007 < 0.001
Trunk fat (g) 12,416.1 ± 5863.6 13,657.9 ±5604.5 0.017
Leg fat (g) 8027.9 ± 3348.6 11,766.8 ± 3946.7 < 0.001
Android fat (g) 1951.4 ± 1134.6 2080 ± 1051.4 0.192
Gynoidfat (g) 3929.1 ± 1597.4 5375.4 ± 1739.6 < 0.001
Android/gynoidfat 0.472 ± 0.09 0.371 ± 0.006 < 0.001
Obesity n (%)a 33(15.8) 98(28.6) 0.001
Abdominal obesity n (%)b 16(7.7) 54(15.8) 0.005
Notes: Data are expressed as mean ± SD; aObesity defined as BMI≥ 30 kg/m2; bAbdominal obesity defined by WC > 88 cm (female) and WC>102 cm (male).
Abbreviations: BMI, Body mass index; WC, Waist circumference; WHtR, Waist to height ratio.
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with most of the CM indicators (r= −0.292 to 0.486, p<
0.001). Within the anthropometric indices, BMI had the
weakest correlation with most CM parameters except for
LDL. WC was strongly correlated with all CM parameters
except for LDL, SBP (r=0.311, P< 0.001), glucose
(r=0.317, P< 0.001), and HDL (r=−0.266, P< 0.001). WC
and WHtR had the highest correlation coefficients with
HOMA and insulin (r= 0.483 and 0.481; r=0.4831 and
Table 2 Cardio-Metabolic Risk Parameters of the Study Population
Variable Male Female P
(N=213) (N= 345)
SBP (mm/Hg) 108.33 ± 0.47 101.71 ± 0.41 < 0.001
DBP (mm/Hg) 64.53 ± 0.51 61.87 ± 0.05 < 0.001
Total cholesterol (mmol/L) 4.56 ± 0.05 4.57 ± 0.04 0.853
LDL (mmol/L) 2.77 ± 0.04 2.59 ± 0.03 0.001
HDL (mmmol/L) 1.40 ± 0.02 1.61 ± 0.02 < 0.001
TG (mmol/L) 0.89 ± 0.03 0.82 ± 0.02 0.031
TG/HDL 0.68 ± 0.36 0.55 ± 0.29 < 0.001
Glucose(mml/L) 5.03 ± 0.46 4.93 ± 0.453 0.017
HbA1C (%) 5.20 ± 0.36 5.19 ± 0.31 0.665
Insulin (μU) 7.68 ± 3.94 8.73 ± 4.54 0.006
HOMA-IR 1.75 ± 0.07 1.95 ± 0.06 0.039
TyG index 4.40 ± 0.01 4.35 ± 0.01 0.009
Low HDL n (%) a 11 (5.2) 69 (20) < 0.001
High LDL n (%)b 24 (11.4) 26 (7.6) 0.13
High Cholesterol n (%)c 12 (5.7) 29 (8.5) 0.23
High TG n (%) d 10 (4.7) 8 (2.3) 0.12
High HOMA-IR n (%)e 23 (4.2) 47 (8.7) 0.448
High TyG n (%)f 63 (11.6) 82 (15.1) 0.002
Prediabetes n (%)g 10 (2.2) 5 9 (1.1) 0.022
Notes: Results are expressed as mean ± SD. aLow HDL defined by HDL<1.04 mmol/L in males and 1.29 mmol/L in females; bHigh LDL defined by LDL>3.5 mmol/L; cHigh
cholesterol defined by total cholesterol>5.5 mmol/L; dHigh TG defined by TG> 1.7 mmol/L; eHigh HOMA-IR defined by HOMA-IR ≥2.28 22; fHigh TyG defined by TyG≥
8.65; gPrediabetes defined by HbA1=5.7–6.4%.
Abbreviations: SBD, Systolic blood pressure; DBP, Diastolic blood pressure; Hb1Ac, Glycated hemoglobin; TG, Triglycerides; HDL, High density lipoprotein cholesterol;
LDL, Low density lipoprotein cholesterol; HOMA, Homeostatic model assessment; TyG, Triglycerides and glucose index.
Table 3 Partially Adjusted Correlations of the Different Adiposity Indicators with Cardiometabolic Risk Parameters
Variable SBP DBP HbA1c TG Glucose HDL LDL HOMA TyG Insulin
Anthropometric data
BMI 0.301c 0.108a 0.191c 0.228c 0.284c −0.212c 0.141c 0.431c 0.283c 0.428c
WC 0.311c 0.150b 0.200c 0.273b 0.317c −0.266c 0.123b 0.483c 0.320c 0.481c
WHtR 0.288c 0.126b 0.198c 0.267c 0.285c −0.260c 0.121b 0.483c 0.306c 0.486c
DXA
TBF 0.291c 0.166c 0.212c 0.246c 0.323c −0.220c 0.142c 0.422c 0.305c 0.414c
Android 0.302c 0.199c 0.210c 0.278 c 0.324c −0.248c 0.131b 0.457c 0.332c 0.451c
Gynoid 0.259c 0.173c 0.191c 0.171c 0.291c −0.169c 0.123b 0.355c 0.237c 0.346c
Leg fat 0.237c 0.118c 0.166c 0.139b 0.267c −0.124b 0.128b 0.311c 0.198 c 0.300c
Trunk fat 0.301c 0.194c 0.222c 0.289c 0.338c −0.256c 0.139c 0.465 c 0.390c 0.457c
Trunk/legs 0.236c 0.171c 0.311c 0.199c −0.292c 0.098a 0.364c 0.325c 0.376c
Android/gynoid 0.249c 0.149b 0.300c 0.240c −0.281c 0.095a 0.418c 0.320c 0.425c
Notes: ap< 0.05; bp< 0.01; cp< 0.001. Values shown are correlation coefficients that were statistically significant (p<0.05; Spearman’s partial correlation). The model used for
analysis was adjusted for age and gender. The highest correlation coefficient is highlighted in bold.
Abbreviations: BMI, Body mass index; WC, waist circumference; WHtR, waist to height ratio; TBF, total body fat; SBD, Systolic blood pressure; DSB, Diastolic blood
pressure; Hb1Ac, Glycated hemoglobin; TG, Triglycerides; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; HOMA, Homeostatic model
assessment; TyG, Triglycerides and glucose index.
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0.486, P< 0.001), respectively. A weak correlation between
DBP, LDL and anthropometric indices was observed.
Results of the DXA–derived indicators demonstrated that
they were significantly correlated with all CM parameters
(P< 0.001). High significant correlations were also observed
between the android fat and SBP, and DBP. Trunk fat was
significantly correlated to TG, glucose, LDL, HOMA, TyG,
and insulin. Moreover, it was observed within the DXA-
indicators, that the ratios of fatness (trunk/leg fat and
android/gynoid fat) showed higher correlation with Hb1Ac
and HDL as compared to the measures of specific fat areas
(trunk fat, leg fat alone). In general, DXA-derived indica-
tors were highly correlated with most CM indicators than
anthropometric indicators.
Figure 1 shows the AUC’s of anthropometric indices and
DXA –derived indicators in the prediction of cardio-
metabolic risk factors. Results demonstrated that the ability
of adiposity indicators to identify CM risk varies, with AUCs
ranging from 0.31 to 0.83. Among the anthropometric
indices, the AUC of WHtR was significantly higher than
that of BMI and WC in the prediction of low HDL, high
LDL, high cholesterol, and high HOMA.WC had the highest
AUC for TG. BMI had the lowest AUC for all CM risk
factors. Among the DXA-derived indicators, fat percentage
has the highest AUC to predict low HDL. Android to gynoid
ratio has the highest AUCs for high LDL, high TG and high
TyG. While trunk fat had the highest AUCs for total choles-
terol, high HDL, and high HOMA. In general, anthropo-
metric indices showed equally ability to predict
abnormality for CM risk factors as DXA-derived indicators.
Discussion
The present study is the first report on the CM risk asso-
ciated with obesity indices using Qatar Biobank data. The
Figure 1 Adjusted area under the ROC curve for body adiposity indicators for predicting selected CM risk factors.
Notes: The model used for analysis was adjusted for age and gender. The highest value for each CM risk is highlighted in bold.
Abbreviations: AUC, Under area receiver operating characteristic (ROC) curve; CM, cardiometabolic; CI, confidence interval; BMI, Body mass index; TG, Triglycerides;
HDL, High density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; HOMA, Homeostatic model assessment; TyG, triglycerides and glucose index.
Dovepress Kerkadi et al
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objective of this study was to compare the ability of
different obesity indicators (anthropometric indicators
and DXA –derived parameters) to predict CM risk
among Qatari adults.
Evidence from numerous studies demonstrated the
association between adiposity and the risk of certain non-
communicable diseases.24–28 Different body adiposity
indicators were associated with CM risk.12,29–37
The major anthropometric indicators used to predict
the CM risk include BMI, WHtR, and WC. BMI is the
most widely used measure to diagnose overweight and
obesity, whereas WC and WHtR better indicator of intra-
abdominal fat, have been suggested to be more accurate to
predict CM than BMI.24,25,27,38–40
Results of the current study demonstrated a significant
correlation between most of the anthropometric indicators
of adiposity and CM risk parameters. The strongest associa-
tions were observed with WHtR and WC. This finding is in
line with other studies.39,41 Konieczna et al reported a poor
association between anthropometric indicators and CM risk
parameters. Results of ROC analysis confirmed the super-
iority of WHtR and to a lesser degree WC based on the
greatest AUC in predicting CM risk.12 Similar results have
been reported by other studies.24,25,27,41 Recently, several
meta-analysis have been published comparing BMI, WC
and WHtR with BMI to elucidate their association
with CM.38,42,43 In a meta-analysis, Ashwell et al reported
the superiority of WHtR over WC and BMI for
detecting CM risk factors in both sexes.38 Results from
the CARRS study conducted in India and Pakistan revealed
that WC and WHtR were the most useful indices for iden-
tifying South Asian adults with prevalent diabetes and
hypertension.24
Results of a study targeting Arab adults indicated that
WC and WHtR were strongly associated with SBP and
DBP, respectively. They also reported a statistically sig-
nificant association between WC, WHtR and glucose
(r=0.34 and 0.33), respectively. The correlation coeffi-
cients of total cholesterol and LDL were 0.28, 0.24, 0.14
and 0.15 for WC and WHtR, respectively. Results revealed
a weak association between WC, WHtR, and HDL (−0.06
and 0.006), respectively. Comparing WC and WHtR,
AUC’s analysis have shown that WC was the most sensi-
tive adiposity index for diabetes mellitus, CVD, hyperten-
sion and metabolic syndrome (AUC=0.6960, AUC=0.795;
AUC= 0.589; AUC=0.813, respectively).4,12,15,44
The results are in line with other studies.4,12,15,45,46 It is
well known that regional fat distribution is strongly
associated with CM risk compared to total fat.47,48 Aparisi
et al reported a high correlation between HDL and% total fat
mass (r=−0.501) for only men, while for TG, the highest
correlation was from the ratio trunk to leg fat mass for men
(r=0.457) and women (r=0.421), respectively.45 Results of
a study targeting postmenopausal women revealed that cen-
tral adiposity indices (android fat, trunk fat, android/gynoid
fat mass, trunk/leg fat mass) were significantly correlated
with HOMA, TG, and inversely correlated with HDL.44
Wiklund et al reported on the association between
abdominal and gynoid fat mass with CM risk factors.
Results revealed a high significantly correlation between
abdominal fat and TG for men (r=0.31) and women
(r=0.33), respectively. The ratio abdominal to gynoid was
highly correlated with cholesterol for men (r=0.32) and
a weak correlation was noted for women (r=0.12). The
highest correlation was observed for abdominal fat and
DBP for men (r=0.34).15 Results of a cross sectional
analysis revealed a statistically significant relationship
between trunk/leg fat, Hb1Ac (r=0.118), TyG (r= 1.160),
and TG (r=0.126). The correlation was negative with HDL
(r= −0.132) and no significant correlations were observed
between the DXA indices, SBP, DBP, and LDL.12
The effect of adipose tissue on the development of non–
communicable diseases (NCD) such as cardiovascular dis-
eases, hypertension, and diabetes mellitus (T2DM) is well
established.49–51 Identifying individuals and population at
risk of NCD constitutes the health priority for clinicians and
public health authorities. Different researches have been
conducted to compare the accuracy of different body adip-
osity indices in predicting CM risks.2,33,52,53 Results of
different studies comparing anthropometric indices with
DXA-derived indicators to select the best adiposity indices
to predict CM risk were controversial.
Results of this study indicated that DXA- derived mea-
surements did not offer advantages over traditional anthro-
pometric indicators in predicting CM risk. Abdominal
obesity indicators (WC and WHtR) showed better ability
to predict dyslipidemia (high cholesterol, high LDL),
while DXA-derived parameters (BF% and trunk/leg fat)
were more accurate to predict low HDL and high TG,
respectively. Our results were consistent with previous
studies.4,29,54 In a study aimed to compare DXA derived
parameters with anthropometric measures to predict the
abdominal aortic calcification (AAC), strong marker of
atherosclerosis among elderly, Shang et al reported that
WC and WHR were the best predictors of AAC severity
among male and female.54
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Another study conducted did not find any advantages
using DXA, as a routine assessment tool, to identify CM
risks associated with obesity.29 Results of a study comparing
the association between adiposity measured by DXA, BMI
and skinfolds and risk markers for CVD and diabetes in adult
males, indicated that BMI was as performant as DXA para-
meters and skinfolds. Strongest correlations for BMI com-
pared to DXA indicators were observed for HDL (R=−0.31,
P< 0.001), TG (R=0.41, P< 0.001), SBP (R=0.31, P< 0.001),
and DBP (R=0.31, P< 0.001), respectively.4
Controversial findings were reported in different stu-
dies. In a cross sectional analysis, Konieczna et al reported
that DXA measures and regional adiposity were the stron-
gest predictors of CM risks than conventional anthropo-
metric measurements.12 Results of AUC’s analysis
indicated that trunk/leg fat had the highest AUC for TG
(AUC=0.556, 95% CI 0.523–0.589), HDL (AUC=0.556,
95% CI 0.523–0.588), and TG/HDL (AUC=0.581, 95% CI
0.546–0.617), respectively. A significant relationship was
also observed between visceral adiposity (VAT) and Type
2 diabetes indicators. The highest AUC’s were observed
for VAT/total fat and HbA1c (AUC=0.629, 95% CI 0.-
567–0.690), and VAT for Tyr (AUC=0.626, 95% CI
0.578–0.674).12 Vasan et al showed a strong association
between android fat, visceral fat, impaired fasting glucose,
and hypertriglyceridemia.55 The Odds ratio (ORs) for
impaired fasting glucose, android fat, and visceral fat
were (OR= 1.93, 95% CI 1.30, 2.88) and (OR= 1.69,
95% CI 1.36, 2.11), respectively. For hypertriglyceride-
mia, ORs were (OR=5.01, 95% CI 3.25, 7.69), and
(OR=3.64, 95% CI 2.82, 4.70) for android fat and visceral
fat, respectively.55
Wiklund et al studied the association between abdom-
inal and gynoid fat mass with the CM risk factors among
adults. It was concluded that abdominal fat and the ratio of
abdominal to gynoid fat were better in predicting CM risks
factors than BMI. We noted that this study compared DXA
parameters only with BMI.15 Similar results have been
reported by other researchers.45,46
The present study had some strengths and limitations.
The Qatar Biobank data included all variables on biomar-
kers, DXA and anthropometric measurements. The study
population was composed of homogenous and healthy
individuals. This study is limited because the cross-
sectional nature of the study does not allow causality
between the study variables and the outcomes. Another
limitation may be attributed to the relative low sample
size.
Conclusions
Results of the present study show that adiposity indicators
(WC and WHtR) are clinically valuable tools used to
identify individuals at risk of CVD. The use of DXA can
provide more in depth data.
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